Trends Of Baseline Cd4 Counts at The Time of Registration of Adult Patient, Who Are Put on Ante Retroviral Therapy in India

Authors

  • Ugra Mohan Jha National AIDS Control Organization, New Delhi, India
  • Sukarma Tanwar WHO India, New Delhi, India
  • B.B Rewari WHO India, New Delhi, India
  • AS Rathore National AIDS Control Organization, New Delhi, India
  • Laxmikant Chavan WHO India, New Delhi, India
  • Neeraj Dhingra National AIDS Control Organization, New Delhi, India

Keywords:

Cd4 count, adult, ART, trend, HIV, India

Abstract

Background:  India has shown considerable progress in prevention and treatment of HIV/AIDS, but timely detection and linkage to HIV treatment still remain a challenge. Understanding the baseline CD4 count level of patients at the time registration, who are put on ART with its trends and associated risk factors, could potentially guide program strategy.

Methods: Data on the levels and trends of baseline CD4 count level of adult (>15 years of age) patients at the time registration are drawn from the patient level data entered in PLHA software from 2007 to 2011.

Results: Out of 727,280 adult patient registered during 2007- 2011; 76.3% were initiated on ART. The baseline median CD4 count levels of adult patients, who were initiated on ART shows increasing  trend during 2007-2011. Gender wise, baseline cd4 count over the year has found significantly higher CD$ in female (p<0.05). In this study also report patient having over 250 cells/mm3 CD4 count have increased during the period 2007 to 2011.

Conclusion: The results indicate increase in median cd4 count level of adult patient registered and put on ART over the year. However, consolidation of universal access to treatment to all is highly felt need.

References

Posse M, Meheus F, van Asten H, van der Ven A, Baltus-sen R. Barriers to access to antiretroviral treatment in de-veloping countries: a review. Trop Med Int Health 2008;13:904-13.

Annual Report: Department of AIDS Control. New Delhi. ; 2011- 12.

“Field Impact Study of NACO Campaign”. New Delhi: Centre for Market Research & Social Development,; 2006.

Halperin DT, Stover J, Reynolds HW. Benefits and costs of expanding access to family planning programs to women living with HIV. Aids 2009;23:S123-S30.

Bachani D, Garg R, Rewari BB, et al. Two-year treatment outcomes of patients entolled in India's national first-line antiretrovital therapy programme. National Medical Journal of India 2010;23:7.

Sogarwal R, Bachani D. Are persons living with HIV timely accessing ART services in India? Journal of the In-dian Medical Association 2009;107:288-90, 307.

Shastri S, Boregowda PH, Rewari BB, Tanwar S, Shet A, Kumar AM. Scaling Up Antiretroviral Treatment Services in Karnataka, India: Impact on CD4 Counts of HIV-Infected People. PloS one 2013;8:e72188.

Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med 2004;5:93-8.

Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Current Opinion in HIV and AIDS 2012;7:99.

Althoff KN, Gange SJ, Klein MB, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clinical infectious diseases 2010;50:1512-20.

Antinori A, Coenen T, Costagiola D, et al. Late presenta-tion of HIV infection: a consensus definition. HIV medi-cine 2011;12:61-4.

Retention in HIV Programmes. Defining the challenges and identifying solutions. Geneva: World Health Organi-sation.; 2011.

Anglemyer A, Rutherford GW, Horvath T, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for preven-tion of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2013;4:CD009153.:10.1002/14651858.CD009153.pub3.

Vives N, Carnicer-Pont D, de Olalla PG, Camps N, Es-teve A, Casabona J. Factors associated with late presen-tation of HIV infection in Catalonia, Spain. International journal of STD & AIDS 2012;23:475-80.

MacKellar DA, Valleroy LA, Secura GM, et al. Unrecog-nized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportu-nities for advancing HIV prevention in the third decade of HIV/AIDS. JAIDS Journal of Acquired Immune Defi-ciency Syndromes 2005;38:603-14.

Downloads

Published

2016-07-31

How to Cite

1.
Jha UM, Tanwar S, Rewari B, Rathore A, Chavan L, Dhingra N. Trends Of Baseline Cd4 Counts at The Time of Registration of Adult Patient, Who Are Put on Ante Retroviral Therapy in India. Natl J Community Med [Internet]. 2016 Jul. 31 [cited 2024 Dec. 21];7(07):582-6. Available from: https://njcmindia.com/index.php/file/article/view/1009

Issue

Section

Original Research Articles